ReviewCurrent drug discovery technologies2026
Edible Vaccines: A Paradigm Shift in Vaccine Delivery and Global Health Solutions.
Review in Current drug discovery technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Edible vaccines represent a revolutionary approach to immunization, leveraging genetically modified plants to produce antigens that elicit immune responses when consumed. This novel strategy addresses several limitations of traditional vaccines, particularly in resource-limited settings, by eliminating the need for cold-chain logistics and skilled healthcare personnel for administration. Edible vaccines can enhance patient compliance, especially among children, by providing a noninvasive method of immunization. Recent advancements have demonstrated the potential of edible vaccines to prevent various infectious diseases. However, challenges remain, including the risk of immune tolerance, variability in antigen dosage, and regulatory hurdles. This review highlights the mechanisms of antigen expression in edible vaccine platforms, engineering strategies to enhance stability and efficacy, and recent clinical trials that underscore their potential impact on global health initiatives.
Indexed as
Identifiers
40698689What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.